A tailored smoking, alcohol, and depression intervention for head and neck cancer patients

Sonia A. Duffy, David L. Ronis, Marcia Valenstein, Michael T. Lambert, Karen E. Fowler, Lynn Gregory, Carol Bishop, Larry L. Myers, Frederic C. Blow, Jeffrey E. Terrell

Research output: Contribution to journalArticle

127 Citations (Scopus)

Abstract

Background: Smoking, alcohol use, and depression are interrelated and highly prevalent in patients with head and neck cancer, adversely affecting quality of life and survival. Smoking, alcohol, and depression share common treatments, such as cognitive behavioral therapy and antidepressants. Consequently, we developed and tested a tailored smoking, alcohol, and depression intervention for patients with head and neck cancer. Methods: Patients with head and neck cancer with at least one of these disorders were recruited from the University of Michigan and three Veterans Affairs medical centers. Subjects were randomized to usual care or nurse-administered intervention consisting of cognitive behavioral therapy and medications. Data collected included smoking, alcohol use, and depressive symptoms at baseline and at 6 months. Results: The mean age was 57 years. Most participants were male (84%) and White (90%). About half (52%) were married, 46% had a high school education or less, and 52% were recruited from Veterans Affairs sites. The sample was fairly evenly distributed across three major head and neck cancer sites and over half (61%) had stage III/IV cancers. Significant differences in 6-month smoking cessation rates were noted with 47% quitting in the intervention compared with 31% in usual care (P < 0.05). Alcohol and depression rates improved in both groups, with no significant differences in 6-month depression and alcohol outcomes. Conclusion: Treating comorbid smoking, problem drinking, and depression may increase smoking cessation rates above that of usual care and may be more practical than treating these disorders separately.

Original languageEnglish (US)
Pages (from-to)2203-2208
Number of pages6
JournalCancer Epidemiology Biomarkers and Prevention
Volume15
Issue number11
DOIs
StatePublished - Nov 2006

Fingerprint

Head and Neck Neoplasms
Smoking
Alcohols
Depression
Cognitive Therapy
Veterans
Smoking Cessation
Antidepressive Agents
Drinking
Nurses
Quality of Life
Education
Survival
Neoplasms

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Duffy, S. A., Ronis, D. L., Valenstein, M., Lambert, M. T., Fowler, K. E., Gregory, L., ... Terrell, J. E. (2006). A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. Cancer Epidemiology Biomarkers and Prevention, 15(11), 2203-2208. https://doi.org/10.1158/1055-9965.EPI-05-0880

A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. / Duffy, Sonia A.; Ronis, David L.; Valenstein, Marcia; Lambert, Michael T.; Fowler, Karen E.; Gregory, Lynn; Bishop, Carol; Myers, Larry L.; Blow, Frederic C.; Terrell, Jeffrey E.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 15, No. 11, 11.2006, p. 2203-2208.

Research output: Contribution to journalArticle

Duffy, SA, Ronis, DL, Valenstein, M, Lambert, MT, Fowler, KE, Gregory, L, Bishop, C, Myers, LL, Blow, FC & Terrell, JE 2006, 'A tailored smoking, alcohol, and depression intervention for head and neck cancer patients', Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 11, pp. 2203-2208. https://doi.org/10.1158/1055-9965.EPI-05-0880
Duffy, Sonia A. ; Ronis, David L. ; Valenstein, Marcia ; Lambert, Michael T. ; Fowler, Karen E. ; Gregory, Lynn ; Bishop, Carol ; Myers, Larry L. ; Blow, Frederic C. ; Terrell, Jeffrey E. / A tailored smoking, alcohol, and depression intervention for head and neck cancer patients. In: Cancer Epidemiology Biomarkers and Prevention. 2006 ; Vol. 15, No. 11. pp. 2203-2208.
@article{38aa5b077b6d4332b16ce2e4e322a6b0,
title = "A tailored smoking, alcohol, and depression intervention for head and neck cancer patients",
abstract = "Background: Smoking, alcohol use, and depression are interrelated and highly prevalent in patients with head and neck cancer, adversely affecting quality of life and survival. Smoking, alcohol, and depression share common treatments, such as cognitive behavioral therapy and antidepressants. Consequently, we developed and tested a tailored smoking, alcohol, and depression intervention for patients with head and neck cancer. Methods: Patients with head and neck cancer with at least one of these disorders were recruited from the University of Michigan and three Veterans Affairs medical centers. Subjects were randomized to usual care or nurse-administered intervention consisting of cognitive behavioral therapy and medications. Data collected included smoking, alcohol use, and depressive symptoms at baseline and at 6 months. Results: The mean age was 57 years. Most participants were male (84{\%}) and White (90{\%}). About half (52{\%}) were married, 46{\%} had a high school education or less, and 52{\%} were recruited from Veterans Affairs sites. The sample was fairly evenly distributed across three major head and neck cancer sites and over half (61{\%}) had stage III/IV cancers. Significant differences in 6-month smoking cessation rates were noted with 47{\%} quitting in the intervention compared with 31{\%} in usual care (P < 0.05). Alcohol and depression rates improved in both groups, with no significant differences in 6-month depression and alcohol outcomes. Conclusion: Treating comorbid smoking, problem drinking, and depression may increase smoking cessation rates above that of usual care and may be more practical than treating these disorders separately.",
author = "Duffy, {Sonia A.} and Ronis, {David L.} and Marcia Valenstein and Lambert, {Michael T.} and Fowler, {Karen E.} and Lynn Gregory and Carol Bishop and Myers, {Larry L.} and Blow, {Frederic C.} and Terrell, {Jeffrey E.}",
year = "2006",
month = "11",
doi = "10.1158/1055-9965.EPI-05-0880",
language = "English (US)",
volume = "15",
pages = "2203--2208",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - A tailored smoking, alcohol, and depression intervention for head and neck cancer patients

AU - Duffy, Sonia A.

AU - Ronis, David L.

AU - Valenstein, Marcia

AU - Lambert, Michael T.

AU - Fowler, Karen E.

AU - Gregory, Lynn

AU - Bishop, Carol

AU - Myers, Larry L.

AU - Blow, Frederic C.

AU - Terrell, Jeffrey E.

PY - 2006/11

Y1 - 2006/11

N2 - Background: Smoking, alcohol use, and depression are interrelated and highly prevalent in patients with head and neck cancer, adversely affecting quality of life and survival. Smoking, alcohol, and depression share common treatments, such as cognitive behavioral therapy and antidepressants. Consequently, we developed and tested a tailored smoking, alcohol, and depression intervention for patients with head and neck cancer. Methods: Patients with head and neck cancer with at least one of these disorders were recruited from the University of Michigan and three Veterans Affairs medical centers. Subjects were randomized to usual care or nurse-administered intervention consisting of cognitive behavioral therapy and medications. Data collected included smoking, alcohol use, and depressive symptoms at baseline and at 6 months. Results: The mean age was 57 years. Most participants were male (84%) and White (90%). About half (52%) were married, 46% had a high school education or less, and 52% were recruited from Veterans Affairs sites. The sample was fairly evenly distributed across three major head and neck cancer sites and over half (61%) had stage III/IV cancers. Significant differences in 6-month smoking cessation rates were noted with 47% quitting in the intervention compared with 31% in usual care (P < 0.05). Alcohol and depression rates improved in both groups, with no significant differences in 6-month depression and alcohol outcomes. Conclusion: Treating comorbid smoking, problem drinking, and depression may increase smoking cessation rates above that of usual care and may be more practical than treating these disorders separately.

AB - Background: Smoking, alcohol use, and depression are interrelated and highly prevalent in patients with head and neck cancer, adversely affecting quality of life and survival. Smoking, alcohol, and depression share common treatments, such as cognitive behavioral therapy and antidepressants. Consequently, we developed and tested a tailored smoking, alcohol, and depression intervention for patients with head and neck cancer. Methods: Patients with head and neck cancer with at least one of these disorders were recruited from the University of Michigan and three Veterans Affairs medical centers. Subjects were randomized to usual care or nurse-administered intervention consisting of cognitive behavioral therapy and medications. Data collected included smoking, alcohol use, and depressive symptoms at baseline and at 6 months. Results: The mean age was 57 years. Most participants were male (84%) and White (90%). About half (52%) were married, 46% had a high school education or less, and 52% were recruited from Veterans Affairs sites. The sample was fairly evenly distributed across three major head and neck cancer sites and over half (61%) had stage III/IV cancers. Significant differences in 6-month smoking cessation rates were noted with 47% quitting in the intervention compared with 31% in usual care (P < 0.05). Alcohol and depression rates improved in both groups, with no significant differences in 6-month depression and alcohol outcomes. Conclusion: Treating comorbid smoking, problem drinking, and depression may increase smoking cessation rates above that of usual care and may be more practical than treating these disorders separately.

UR - http://www.scopus.com/inward/record.url?scp=33845303206&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845303206&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-05-0880

DO - 10.1158/1055-9965.EPI-05-0880

M3 - Article

C2 - 17119047

AN - SCOPUS:33845303206

VL - 15

SP - 2203

EP - 2208

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 11

ER -